Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Allena Pharmaceuticals Inc. (ALNA)

2.11   -0.13 (-5.8%) 02-14 16:00
Open: 2.28 Pre. Close: 2.24
High: 2.28 Low: 2.06
Volume: 497,577 Market Cap: 50M
Allena Pharmaceuticals Inc is a clinical biopharmaceutical company. It focuses on developing and commercializing oral enzyme therapeutics to treat patients with rare and severe metabolic and kidney disorders.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 2.295 - 2.317 2.317 - 2.33
Low: 2.016 - 2.043 2.043 - 2.059
Close: 2.079 - 2.123 2.123 - 2.15

Technical analysis

as of: 2020-02-14 4:26:29 PM
Overall:       
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 3.00     One year: 3.41
Support: Support1: 2.00    Support2: 1.66
Resistance: Resistance1: 2.57    Resistance2: 2.92
Pivot: 2.47
Moving Average: MA(5): 2.33     MA(20): 2.50
MA(100): 3.09     MA(250): 4.41
MACD: MACD(12,26): -0.05     Signal(9):
Stochastic oscillator: %K(14,3): 25.00     %D(3): 36.71
RSI: RSI(14): 38.16
52-week: High: 7.95  Low: 1.55  Change(%): -69.9
Average Vol(K): 3-Month: 32145  10-Days: 37129

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
ALNA has closed above bottom band by 10.9%. Bollinger Bands are 44.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to ALNA's normal range. The bands have been in this narrow range for 53 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

2019-11-14
Allena Pharmaceuticals (NASDAQ:ALNA) Issues Quarterly Earnings Results, Misses Estimates By $0.08 EPS
Allena Pharmaceuticals (NASDAQ:ALNA) announced its earnings results on Wednesday. The company reported ($0.57) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.49) by ($0.08), Fidelity Earnings reports. NASDAQ ALNA traded down $0.05 during trading on Thursday, hitting $1.64. 399,900 shares of the company’s stock traded hands, compared to its average volume […]

2019-11-14
The Daily Biotech Pulse: Amarin Braces For Vascepa Adcom Verdict, Biotechs On A Fundraising Spree, Zosano Makes Progress With Migraine Drug Filing
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs Nov. 13.) Antares Pharma Inc (NASDAQ: ATRS ) Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR ) Bausch Health Companies Inc (NYSE: BHC ) BioDelivery Sciences International, Inc. (NASDAQ: BDSI ) (reacted to its third-quarter results) Bristol-Myers Squibb Co (NYSE: BMY ) Celgene Corporation (NASDAQ: CELG ) China Biologic Products Holdings Inc (NASDAQ: CBPO ) Deciphera Pharmaceuticals Inc (NASDAQ: DCPH ) Dicerna Pharmaceuticals Inc (NASDAQ: DRNA ) Edwards Lifesciences Corp (NYSE: EW ) ESSA Pharma Inc (NASDAQ: EPIX ) GALAPAGOS NV/S ADR (NASDAQ: GLPG ) GENMAB A/S/S ADR (NASDAQ: GMAB ) Halozyme Therapeutics, Inc. (NASDAQ: HALO ) (reacted to its third-quarter results) IGM Biosciences Inc (NASDAQ: IGMS ) Insulet Corporation (NASDAQ: PODD ) Krystal Biotech Inc (NASDAQ: KRYS ) Opiant Pharmaceuticals Inc (NASDAQ: OPNT ) ( reported an unexpected profit for its third quarter) Recro Pharma Inc (NASDAQ: REPH ) Seattle Genetics, Inc. (NASDAQ: SGEN ): filed an arbitration demand to settle dispute with DAIICHI SANKYO/S ADR (OTC: DSNKY ).

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  Nasdaq Global Select
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 23.47
Shares Float (M) 9.05
% Held by Insiders 12.46
% Held by Institutions 82.44
Shares Short (K) 664
Shares Short P. Month (K)

Stock Financials

EPS -2.121
Book Value (p.s.) 1.070
PEG Ratio
Profit Margin
Operating Margin
Return on Assets (ttm) -49.5
Return on Equity (ttm) -109.0
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -1.954
Qtrly Earnings Growth
Operating Cash Flow (M) -40.42
Levered Free Cash Flow (M) -24.09

Stock Valuations

P/E -0.99
P/E Growth Ratio -0.06
P/BV 1.97
P/S
P/CF -1.23

Dividends & Splits

Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.